A.C. van Grootheest
Impact in
- Toxicology top 0.2%
- Pharmacovigilance and Adverse Drug Reactions
- Geriatrics and Gerontology top 5%
- Pharmaceutical Practices and Patient Outcomes
Papers in
- Toxicology 14
- Pharmacovigilance and Adverse Drug Reactions 14
-
- Pharmaceutical Economics and Policy 4
- Co-authors
- Linda Härmark (4 shared papers)Lolkje T.W. de Jong‐van den Berg (4 shared papers)Eugène van Puijenbroek (9 shared papers)Mark de Groot (3 shared papers)H.E. van der Wiel (1 shared paper)Anneke Passier (1 shared paper)G.A.J. Dunselman (1 shared paper)Jerry Labadie (2 shared papers)
- Journals
- Drug Safety (7 papers)International Journal of Pharmacy Practice (2 papers)Pharmacoepidemiology and Drug Safety (2 papers)British Journal of Clinical Pharmacology (1 paper)Regulatory Toxicology and Pharmacology (1 paper)
- Partner nations
- NetherlandsNew ZealandGhana
In The Last Decade
A.C. van Grootheest
22 papers receiving 625 citations
Peers
Comparison fields: 5 of 75
- Toxicology 377
- Geriatrics and Gerontology 74
- Gastroenterology 32
- Pharmacology 50
- Applied Microbiology and Biotechnology 10
Countries citing papers authored by A.C. van Grootheest
This map shows the geographic impact of A.C. van Grootheest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.C. van Grootheest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.C. van Grootheest more than expected).
Fields of papers citing papers by A.C. van Grootheest
This network shows the impact of papers produced by A.C. van Grootheest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.C. van Grootheest. The network helps show where A.C. van Grootheest may publish in the future.
Co-authors
The 16 scholars most cited alongside A.C. van Grootheest, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 215 | |
| 2 | 2005 | 84 | |
| 3 | 2007 | 82 | |
| 4 | 2002 | 63 | |
| 5 | 2002 | 51 | |
| 6 | 2005 | 51 | |
| 7 | [Direct reporting of side effects by the patient: favourable experience in the first year]. | 2005 | 33 |
| 8 | [Severe adverse reactions after the use of sulphur hexafluoride (SonoVue) as an ultrasonographic contrast agent]. | 2004 | 21 |
| 9 | 2007 | 18 | |
| 10 | Improving pharmacovigilance and the role of the pharmacist | 2003 | 11 |
| 11 | 2006 | 6 | |
| 12 | 2003 | 5 | |
| 13 | 2007 | 5 | |
| 14 | 2013 | 4 | |
| 15 | 2011 | 4 | |
| 16 | 2012 | 4 | |
| 17 | 2007 | 3 | |
| 18 | [Adverse events following vaccination reported to the Netherlands Pharmacovigilance Center Lareb in 2004-2006]. | 2007 | 2 |
| 19 | 2006 | 2 | |
| 20 | Patients' role in reporting adverse drug reactions | 2004 | 1 |
About A.C. van Grootheest
A.C. van Grootheest is a scholar working on Toxicology, Economics and Econometrics, Pediatrics, Perinatology and Child Health, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 669 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (14 papers), Pharmaceutical Economics and Policy (4 papers), Pharmaceutical studies and practices (3 papers), Pharmaceutical Practices and Patient Outcomes (2 papers), Academic integrity and plagiarism (1 paper), Restless Legs Syndrome Research (1 paper), Epilepsy research and treatment (1 paper) and Pharmaceutical industry and healthcare (1 paper). The work is most often cited by research in Toxicology (377 citations), Geriatrics and Gerontology (74 citations), Gastroenterology (32 citations), Pharmacology (50 citations) and Applied Microbiology and Biotechnology (10 citations). A.C. van Grootheest has collaborated with scholars based in Netherlands, New Zealand and Ghana. Frequent co-authors include Linda Härmark, Lolkje T.W. de Jong‐van den Berg, Eugène van Puijenbroek, Mark de Groot, H.E. van der Wiel, Anneke Passier, G.A.J. Dunselman, Jerry Labadie, Rachel Richesson and Lorna Renner. Their work appears in journals such as Drug Safety, International Journal of Pharmacy Practice, Pharmacoepidemiology and Drug Safety, British Journal of Clinical Pharmacology and Regulatory Toxicology and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.